Procalcitonin levels during pregnancy, delivery and postpartum

Journal of Perinatal Medicine

Volumn 39, Issue 6, 2011, Pages 679-683

  Paccolat, Céline ^a   Harbarth, Stephan ^a   Courvoisier, Delphine ^a   Irion, Olivier ^a   DeTejada, Begoña Martinez ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Delivery; normal values range; postpartum; pregnancy; procalcitonin

Indexed keywords

PROCALCITONIN;

ADULT; ARTICLE; CESAREAN SECTION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; NORMAL HUMAN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SENSITIVITY ANALYSIS; THIRD TRIMESTER PREGNANCY; VAGINAL DELIVERY;

ADULT; CALCITONIN; COHORT STUDIES; FEMALE; HUMANS; PARTURITION; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REFERENCE VALUES; YOUNG ADULT;

EID: 80955126691     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.082     Document Type: Article

References (23)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations inpatients with sepsis and infection. Lancet. 1993;341:515-8.
2. Assumma M, Signore F, Pacifico L, Rossi N, Osborn JF,Chiesa C. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinalstudy. Clin Chem. 2000;46:1583-7.
3. Bolke E, Jehle PM, Graf M, Baier A, Wiedeck H, SteinbachG, et al. Inflammatory response during abdominal and thyroid surgery: a prospective clinical trial on mediator release. Shock. 2001;16:334-9.
4. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 375: 463-74.
5. Branch DW. Physiologic adaptations of pregnancy. Am J Reprod Immunol. 1992;28:120-2.
6. Chen FC, Sarioglu N, Buscher U, Dudenhausen JW. Lipopolysaccharide binding protein in the early diagnosis of intraamniotic infection of pregnant women with premature rupture of the membranes. J Perinat Med. 2009;37:135-9.
7. Christ-Crain M, Muller B. Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly. 2005; 135:451-60.
8. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol. 1995;22:281-342.
9. Graf J-D. La procalcitonine, un marqueur (idéal?) des états septiques. Pipette. 2007;6:12-5.
10. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396-402.
11. Hausfater P. Procalcitonin measurement in adult clinical practice. Rev Med Interne. 2007;28:296-305.
12. Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction. 2009;138:903-19.
13. Maier M, Wutzler S, Lehnert M, Szermutzky M, Wyen H, Bingold T, et al. Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J Trauma. 2009; 66:243-9.
14. Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007;7:10.
15. Müller B, Schuetz P, Christ-Crain M. Procalcitonine. Forum Med Suisse. 2008;8:388-90.
16. OShea TM, Klinepeter KL, Meis PJ, Dillard RG. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants. Paediatr Perinat Epidemiol. 1998;12:72-83.
17. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. J Am Med Assoc. 2009;302:1059-66.
18. Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections - hope for hype? Swiss Med Wkly. 2009;139: 318-26.
19. Sereepapong W, Limpongsanurak S, Triratanachat S, Wannakrairot P, Charuruks N, Krailadsiri P. The role of maternal serum C-reactive protein and white blood cell count in the prediction of chorioamnionitis in women with premature rupture of membranes. J Med Assoc Thai. 2001;84(Suppl 1): S360-6.
20. Torbe A. Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm. 2007;2007:35782.
21. Torbe A, Czajka R. Maternal plasma procalcitonin concentrations in patients with preterm labor and intact membranes - prediction of preterm delivery and admission-to-delivery interval. J Perinat Med. 2004;32:332-6.
22. Torbe A, Czajka R. Are vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes? J Obstet Gynaecol Res. 2005;31:464-70.
23. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. Br J Obstet Gynaecol. 2007;114:796-801.